Financing ·
Femasys Inc. entered into a private placement agreement on August 7, 2026, closing on August 10, 2026, to raise…
FEMYFemasys Inc
Femasys Inc. entered into a private placement agreement on August 7, 2026, closing on August 10, 2026, to raise approximately $30 million in gross proceeds. The company issued 5,013,559 shares of common stock at $3.20 per share and pre-funded warrants for 4,361,440 additional shares at $3.1999 each. Accompanying these instruments were two warrant series totaling 18,749,998 shares: Common Warrants exercisable immediately at $2.95 per share, and Milestone Warrants exercisable upon achieving specific revenue and stock price targets, also at $2.95 per share. Five executives participated in the offering, purchasing approximately $134,000 of securities on identical terms. Additionally, Nantahala Capital Management LLC terminated its rights to designate board members and observers under a prior convertible note agreement. Femasys Inc. operates in the medical device industry, developing minimally invasive treatments for pelvic organ prolapse.